SH

Scott Heysell

Associate Professor
Unit: School of Medicine
Department: Department of Medicine, Infectious Diseases
Office location and address
345 Crispell Dr
Charlottesville, Virginia 22903
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
Source: U.S. NIH Institute of Allergy & Infectious Disease
September 18, 2020 – June 30, 2025
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
Source: U.S. NIH Institute of Allergy & Infectious Disease
June 01, 2020 – August 31, 2023
Halting the dual tuberculosis and diabetes epidemic in Tanzania
Source: Københavns Universitet
April 01, 2018 – March 31, 2023
A Phase 2b Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults with Different Rabies Exposure Risks
Source: PPD Investigator Services, LLC
November 11, 2019 – November 10, 2022
Glycaemia dynamics and the impact on the tuberculosis-diabetes epidemic in Bangladesh
Source: American Society of Tropical Medicine and Hygiene
July 01, 2021 – June 30, 2022
Research capacity strengthening programme for emerging and re-emerging infectious diseases control in Tanzania
Source: Kibong'oto Infectious Diseases (KIDH)
April 01, 2018 – March 31, 2022
Clinical course and outcomes of people with coronavirus disease and tuberculosis: a multicentre cohort study
Source: The Tuberculosis Foundation of Virginia, Inc.
April 01, 2021 – March 31, 2022
MD-INMD-ID Diagnostics and Pharmacotherapy for Severe Forms of TB
Source: U.S. NIH Institute of Allergy & Infectious Disease
August 15, 2015 – January 31, 2022
NIMR - MMRC RISE Study
Source: NIMR - Mbeya Medical Research Centre
December 16, 2020 – December 16, 2021
Clofazimine for the treatment of multidrug-resistant tuberculosis in Virginia
Source: The Tuberculosis Foundation of Virginia, Inc.
July 10, 2019 – June 30, 2021
MD-INMD-ID-SKH8R-R01-RF Individualized approaches to the HIV/TB epidemic among polysubstance users in Irkutsk
Source: U.S. NIH Institute on Drug Abuse
May 01, 2017 – February 28, 2021
Bridge Irkutsk: Scaling up testing for target populations and linkage to and retention in care for PLHIV
Source: Warm Health Technology, Inc.
November 01, 2019 – December 31, 2020
Saliva & dried blood spot TDM for fluoroquinolones in MDRTB
Source: University Medical Center Groningen
October 02, 2019 – October 01, 2020
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
Source: Rutgers, The State University of New Jersey
September 24, 2018 – March 20, 2020
Clofazimine for the treatment of multidrug-resistant tuberculosis in Virginia
Source: The Tuberculosis Foundation of Virginia, Inc.
December 08, 2017 – December 07, 2018
MD-INMD Use of 18-fluorodeoxyglucose positron emission tomography (FDG-PET) in TB cases from Virginia
Source: The Tuberculosis Foundation of Virginia, Inc.
May 01, 2013 – February 26, 2018
MD-INMD Clinical Impact of Anti-TB Drug Levels and M. Tuberculosis Susceptibility
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 15, 2012 – August 31, 2017
Clinical Impact of Anti-TB Drug Levels and M. Tuberculosis Susceptibility
Source: U.S. NIH Institute of Allergy & Infectious Disease
July 15, 2012 – June 30, 2016
American Society of tropical Medicine and Hygiene
Source: Burroughs Wellcome Fund
August 13, 2012 – June 30, 2015